BRPI0407156A - Epìtopos de proteção cruzada de moraxella catarrhalis e processos para uso dos mesmos - Google Patents

Epìtopos de proteção cruzada de moraxella catarrhalis e processos para uso dos mesmos

Info

Publication number
BRPI0407156A
BRPI0407156A BR0407156-5A BRPI0407156A BRPI0407156A BR PI0407156 A BRPI0407156 A BR PI0407156A BR PI0407156 A BRPI0407156 A BR PI0407156A BR PI0407156 A BRPI0407156 A BR PI0407156A
Authority
BR
Brazil
Prior art keywords
moraxella catarrhalis
cross
processes
protection
epitopes
Prior art date
Application number
BR0407156-5A
Other languages
English (en)
Inventor
Dai-Fang Liu
John Calhoun Mcmichael
Steven Morris Baker
Leah Diane Flecher
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of BRPI0407156A publication Critical patent/BRPI0407156A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A61K39/1045—Moraxella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

"EPìTOPOS DE PROTEçãO CRUZADA DE MORAXELLA CATARRHALIS E PROCESSOS PARA USO DOS MESMOS". A presente invenção refere-se amplamente às composições imunogênicas para a administração a um hospedeiro suscetível à infecção por Moraxella catarrhalis. Mais particularmente, a invenção se direciona a uma identificação de seq³ências de epítopos com reação cruzada da proteína CopB de Moraxella catarrhalis.
BR0407156-5A 2003-01-30 2004-01-27 Epìtopos de proteção cruzada de moraxella catarrhalis e processos para uso dos mesmos BRPI0407156A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44360003P 2003-01-30 2003-01-30
PCT/US2004/002383 WO2004069163A2 (en) 2003-01-30 2004-01-27 Cross-protective epitopes of moraxella catarrhalis and use thereof

Publications (1)

Publication Number Publication Date
BRPI0407156A true BRPI0407156A (pt) 2006-02-07

Family

ID=32850788

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407156-5A BRPI0407156A (pt) 2003-01-30 2004-01-27 Epìtopos de proteção cruzada de moraxella catarrhalis e processos para uso dos mesmos

Country Status (11)

Country Link
US (1) US20060147470A1 (pt)
EP (1) EP1587826A2 (pt)
JP (1) JP2006518379A (pt)
KR (1) KR20050099517A (pt)
CN (1) CN1745096A (pt)
AU (1) AU2004210158A1 (pt)
BR (1) BRPI0407156A (pt)
CA (1) CA2513259A1 (pt)
IL (1) IL169533A0 (pt)
MX (1) MXPA05007890A (pt)
WO (1) WO2004069163A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2716661B1 (en) 2011-06-01 2018-03-07 Xiamen University Fusion protein comprising diphtheria toxin non-toxic mutant crm197 or fragment thereof
CN110540596B (zh) * 2018-12-20 2021-04-06 湖北工业大学 基于卡他莫拉菌表面蛋白抗体的卡他莫拉菌Elisa检测试剂盒及制备方法
JP6964161B2 (ja) * 2020-04-06 2021-11-10 旭化成株式会社 検体中のモラクセラ・カタラーリス菌を検出するための抗体、並びに斯かる抗体を用いてモラクセラ・カタラーリス菌を検出するための方法、試薬、及びキット

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5993826A (en) * 1993-03-02 1999-11-30 Board Of Regents, The University Of Texas Methods and compositions relating to useful antigens of moraxella catarrhalis
CA2262748A1 (en) * 1996-08-12 1998-02-19 Board Of Regents, The University Of Texas System Defining epitopes of the outer membrane protein copb of moraxella catarrhalis

Also Published As

Publication number Publication date
US20060147470A1 (en) 2006-07-06
WO2004069163A2 (en) 2004-08-19
CA2513259A1 (en) 2004-08-19
CN1745096A (zh) 2006-03-08
KR20050099517A (ko) 2005-10-13
AU2004210158A1 (en) 2004-08-19
EP1587826A2 (en) 2005-10-26
MXPA05007890A (es) 2005-09-21
JP2006518379A (ja) 2006-08-10
WO2004069163A3 (en) 2005-06-02
IL169533A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
BR0313041A (pt) Compostos; composições farmacêuticas; método para o tratamento e/ou profilaxia de doenças que estão associadas à modulação dos receptores de cb1; e uso de compostos
BR0213207A (pt) remodelagem e glicoconjugação de peptìdeos
BR0308261A (pt) Métodos extrativos para puruficação de sucralose
FI940681A0 (fi) Menetelmä ja koostumuksia, jotka liittyvät Moraxella catarrhalisin käyttökelpoisiin antigeeneihin
CA2234409A1 (en) Transferrin receptor protein of moraxella
ATE194291T1 (de) Neutralisierende monoklonale antikörper gegen respiratorischen synzytialvirus
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
BRPI9701774B8 (pt) cdna mutante e infeccioso do vírus da febre amarela, constructo de dna, vírus recombinante de febre amarela e vacina para humanos contra infecções de febre amarela.
BR0211761A (pt) depsipeptìdeos e processos para preparar os mesmos
PH12021550441A1 (en) Modified pedv spike protein
DE69940406D1 (de) Ine rsv untereinheit zusammensetzung und ein influenzavirus präparat enthält
BRPI0407156A (pt) Epìtopos de proteção cruzada de moraxella catarrhalis e processos para uso dos mesmos
BR0303912A (pt) Composição para o condicionamento, composição para o condicionamento durável, método para o condicionamento, método para o condicionamento durável, método para o cuidado ou tratamento e kit para o cuidado, tratamento, condicionamento ou condicionamento durável
DE69432137D1 (de) Impfstoff gegen Geflügelkokzidose
WO2021202599A3 (en) Adeno-associated virus based compositions and related methods for inducing humoral immunity
DE60305884D1 (de) Igg3 immunogloblin als schutzsmarker gegen viren infektiösen krankheiten und seine verwendungen
DE69521007D1 (de) Impfstoff gegen Geflügelkokzidose
ATE401912T1 (de) Methoden der zubereitung von immunglobulin und dessen verwendungen
ATE154244T1 (de) Induzierung eines schutzes gegen virale infektionen
ATE471156T1 (de) Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
BRPI0414073A (pt) método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo
ATE303821T1 (de) Neue vakzinformulierung aus dna-vakzine- inaktiviertem virus
HUP0202893A2 (hu) Szubsztituált benziltiazolidin-2,4-dion-származékok és ezeket tartalmazó gyógyászati készítmények

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.